Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind Placebo Controlled Trial on the Effect of Stablor™ on the Abdominal Visceral Fat Mass Loss in Patients With a Metabolic Syndrome

NCT01755104 is registered in ClinicalTrials.gov with Laboratoires Nutrition et Cardiometabolisme as lead sponsor.

NCT NCT01755104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01755104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind Placebo Controlled Trial on the Effect of Stablor™ on the Abdominal Visceral Fat Mass Loss in Patients With a Metabolic Syndrome
Lead sponsor
Laboratoires Nutrition et Cardiometabolisme
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
February 28, 2014
Enrollment
118 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome